Polaris Entrepreneurs' Fund Vii, L.p. - Net Worth and Insider Trading
Polaris Entrepreneurs' Fund Vii, L.p. Net Worth
The estimated net worth of Polaris Entrepreneurs' Fund Vii, L.p. is at least $10,448 dollars as of 2024-09-20. Polaris Entrepreneurs' Fund Vii, L.p. is the 10% Owner of SQZ Biotechnologies Co and owns about 254,931 shares of SQZ Biotechnologies Co (SQZB) stock worth over $10,197. Polaris Entrepreneurs' Fund Vii, L.p. is also the 10% Owner of Metacrine Inc and owns about 178,942 shares of Metacrine Inc (MTCR) stock worth over $251. Details can be seen in Polaris Entrepreneurs' Fund Vii, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Polaris Entrepreneurs' Fund Vii, L.p. has not made any transactions after 2020-11-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Polaris Entrepreneurs' Fund Vii, L.p.
Polaris Entrepreneurs' Fund Vii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Polaris Entrepreneurs' Fund Vii, L.p. owns 3 companies in total, including Syros Pharmaceuticals Inc (SYRS) , SQZ Biotechnologies Co (SQZB) , and Metacrine Inc (MTCR) .
Insider Ownership Summary of Polaris Entrepreneurs' Fund Vii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2016-06-29 | 10 percent owner |
| SQZB | SQZ Biotechnologies Co | 2020-11-03 | 10 percent owner |
| MTCR | Metacrine Inc | 2020-09-18 | 10 percent owner |
Polaris Entrepreneurs' Fund Vii, L.p. Latest Holdings Summary
Polaris Entrepreneurs' Fund Vii, L.p. currently owns a total of 2 stocks. Among these stocks, Polaris Entrepreneurs' Fund Vii, L.p. owns 254,931 shares of SQZ Biotechnologies Co (SQZB) as of November 3, 2020, with a value of $10,197 and a weighting of 97.6%. Polaris Entrepreneurs' Fund Vii, L.p. also owns 178,942 shares of Metacrine Inc (MTCR) as of September 18, 2020, with a value of $251 and a weighting of 2.4%.
Latest Holdings of Polaris Entrepreneurs' Fund Vii, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SQZB | SQZ Biotechnologies Co | 2020-11-03 | 254,931 | 0.04 | 10,197 |
| MTCR | Metacrine Inc | 2020-09-18 | 178,942 | 0.00 | 251 |
Holding Weightings of Polaris Entrepreneurs' Fund Vii, L.p.
Polaris Entrepreneurs' Fund Vii, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Polaris Entrepreneurs' Fund Vii, L.p. has made a total of 1 transactions in SQZ Biotechnologies Co (SQZB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in SQZ Biotechnologies Co is the acquisition of 25,000 shares on November 3, 2020, which cost Polaris Entrepreneurs' Fund Vii, L.p. around $4 Million.
According to the SEC Form 4 filings, Polaris Entrepreneurs' Fund Vii, L.p. has made a total of 1 transactions in Metacrine Inc (MTCR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Metacrine Inc is the acquisition of 230,000 shares on September 18, 2020, which cost Polaris Entrepreneurs' Fund Vii, L.p. around $3 Million.
Insider Trading History of Polaris Entrepreneurs' Fund Vii, L.p.
- 1
Polaris Entrepreneurs' Fund Vii, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Polaris Entrepreneurs' Fund Vii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Polaris Entrepreneurs' Fund Vii, L.p. is 20.74%. GuruFocus also compares Polaris Entrepreneurs' Fund Vii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Polaris Entrepreneurs' Fund Vii, L.p. within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Polaris Entrepreneurs' Fund Vii, L.p.'s insider trading performs compared to the benchmark.
Performance of Polaris Entrepreneurs' Fund Vii, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 38.16 | | | | | |
| Relative Return to S&P 500(%) | 31.27 | | | | | |
Polaris Entrepreneurs' Fund Vii, L.p. Ownership Network
Polaris Entrepreneurs' Fund Vii, L.p. Owned Company Details
What does Syros Pharmaceuticals Inc do?
Who are the key executives at Syros Pharmaceuticals Inc?
Polaris Entrepreneurs' Fund Vii, L.p. is the 10 percent owner of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Financial Officer Jason Haas , Chief Commercial Officer Chee Conley , and Chief Medical Officer David Roth .
Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary
Over the past 18 months, Polaris Entrepreneurs' Fund Vii, L.p. made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net purchase of 100,000 shares made by Chee Conley .
In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 200,000 shares, with a net purchase of 200,000 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 1,104,977 shares were bought by its insiders, resulting in a net purchase of 1,073,765 shares.
Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syros Pharmaceuticals Inc Insider Transactions
Polaris Entrepreneurs' Fund Vii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Polaris Entrepreneurs' Fund Vii, L.p.. You might contact Polaris Entrepreneurs' Fund Vii, L.p. via mailing address: One Marina Park Drive, 10th Floor, Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
